Unknown

Dataset Information

0

Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.


ABSTRACT: Taxane is one of the first line treatments of lung cancer. In order to identify novel single nucleotide polymorphisms (SNPs) that might contribute to taxane response, we performed a genome-wide association study (GWAS) for two taxanes, paclitaxel and docetaxel, using 276 lymphoblastoid cell lines (LCLs), followed by genotyping of top candidate SNPs in 874 lung cancer patient samples treated with paclitaxel.GWAS was performed using 1.3 million SNPs and taxane cytotoxicity IC50 values for 276 LCLs. The association of selected SNPs with overall survival in 76 small or 798 non-small cell lung cancer (SCLC, NSCLC) patients were analyzed by Cox regression model, followed by integrated SNP-microRNA-expression association analysis in LCLs and siRNA screening of candidate genes in SCLC (H196) and NSCLC (A549) cell lines.147 and 180 SNPs were associated with paclitaxel or docetaxel IC50s with p-values <10-4 in the LCLs, respectively. Genotyping of 153 candidate SNPs in 874 lung cancer patient samples identified 8 SNPs (p-value?

SUBMITTER: Niu N 

PROVIDER: S-EPMC3573965 | biostudies-literature | 2012 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.

Niu Nifang N   Schaid Daniel J DJ   Abo Ryan P RP   Kalari Krishna K   Fridley Brooke L BL   Feng Qiping Q   Jenkins Gregory G   Batzler Anthony A   Brisbin Abra G AG   Cunningham Julie M JM   Li Liang L   Sun Zhifu Z   Yang Ping P   Wang Liewei L  

BMC cancer 20120924


<h4>Background</h4>Taxane is one of the first line treatments of lung cancer. In order to identify novel single nucleotide polymorphisms (SNPs) that might contribute to taxane response, we performed a genome-wide association study (GWAS) for two taxanes, paclitaxel and docetaxel, using 276 lymphoblastoid cell lines (LCLs), followed by genotyping of top candidate SNPs in 874 lung cancer patient samples treated with paclitaxel.<h4>Methods</h4>GWAS was performed using 1.3 million SNPs and taxane cy  ...[more]

Similar Datasets

| S-EPMC3412624 | biostudies-literature
| S-EPMC4055088 | biostudies-literature
| S-EPMC3691078 | biostudies-literature
| S-EPMC2963812 | biostudies-literature
| S-EPMC6078562 | biostudies-literature
| S-EPMC4292778 | biostudies-literature
| S-EPMC3576867 | biostudies-literature
| S-EPMC3719971 | biostudies-literature
| S-EPMC4879713 | biostudies-literature
| S-EPMC8743030 | biostudies-literature